Industry
ValenTx, Inc.
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 4 trials
Success Rate
100.0%
+13.4% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
N/A
4(100.0%)
4Total
N/A(4)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT02954003Not ApplicableUnknown
The ValenTx Endo Bypass System in Obese Subjects
Role: lead
NCT02954016Not ApplicableUnknown
The ePass Clinical Trial for the Treatment of Obese Subjects
Role: lead
NCT01207830Not ApplicableCompleted
Feasibility Trial of ValenTx Endo Bypass System of the ValenTx Endo Bypass System in Obese Subjects
Role: lead
NCT01207804Not ApplicableCompleted
Feasibility Trial of ValenTx Endo Bypass System
Role: lead
All 4 trials loaded